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and hormones have been implicated in the regulation of growth plate
biology, however, less is known about the intracellular signaling pathways
involved. In addition numerous genes involved in growth plate develop-
ment are also up-regulated in articular chondrocytes in Osteoarthritis
(OA), such as hypertrophic chondrocyte markers collagen X and MMP13,
suggesting that learning about the signaling mechanisms involved in
endochondral bone growth will also help us ﬁnd targets genes responsible
for cartilage destruction.
Publications from our laboratory and others have shown that C-type natri-
uretic peptide (CNP) has an anabolic effect on bone growth, speciﬁcally
through increasing the length of hypertrophic zone of the growth plate and
that the PI3K and p38 MAPK pathways are required for this regulation.
Since we have shown that the main effect of the p38 and PI3K inhibition is
decreased hypertrophic zone length, we wanted to investigate the effect
of the two pathways on the genes differentially expressed between the
hypertrophic and the resting/proliferating zones.
Methods: RNA was isolated from primary chondrocytes after 24 hours
of culture in the presence of LY294002, SB202190 or DMSO from
three independent trials and then hybridized to Affymetrix MOE 430
2.0 gene chips. GSEA algorithm was implemented in order to analyze
the effect of our experimental conditions (treatment with SB202190 or
LY294002) on known biological pathways and functional categories. The
expression of selected genes was also conﬁrmed by real-time PCR.
Differentially regulated genes grouped in functional categories, common
to both treatments, were compared to genes found to be differentially
expressed between the hypertrophic and the resting/proliferating zones of
previously dissected growth plates. RNA was isolated from E15.5 mouse
embryo microdissected growth plates from three different trials and also
hybridized to MOE430 2.0. gene chips.
Results: Numerous gene sets grouped in functional categories were
found commonly regulated by the two pathways. In addition we in-
tersected these genes with genes found to be differentially regulated
between the hypertrophic and proliferative/resting zone. Common genes
found to be up-regulated in the hypertrophic zone compared to the
resting/proliferating zone and also decreased in both LY294002 and
SB202190 treatments such as Phlda2 (pleckstrin homology-like domain,
family A, member 2, also known as Ipl) and F13a1 (coagulation factor
XIII, A1 subunit) were also conﬁrmed by real-time PCR. These are just a
few examples of target genes of the two pathways and that also seem to
be important in hypertrophic chondrocyte differentiation. In addition genes
that were found to have decreased levels of expression in the hypertrophic
zone and up regulated in SB202190 and LY294002 treatments such as
LTBP3 (latent transforming growth factor beta binding protein 3) were
also conﬁrmed by real-time PCR. These genes are probably involved in
earlier stages of chondrocyte differentiation and proliferation.
Conclusions: Our data suggest that genes commonly regulated by the
two signaling pathways p38 and PI3k are also involved in hypertrophic
chondrocyte differentiation. For example some of genes down-regulated
by both pathways were also found to be increased in the hypertrophic
zone compared to the resting/proliferating zone, making them good
candidates for further analyses in both growth plate chondrocytes and
articular chondrocytes.
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Purpose: Autologous chondrocyte implantation (ACI) techniques are
widely used for the treatment of chondral defects in the knee. Several MRI
techniques have been used to assess cartilage properties in vivo after
chondrocyte transplantation. There is little known about the behaviour of
biochemical composition of repair tissue (RT) over time.
The aim of our study was to prospectively assess the biochemical proper-
ties of cartilage repair tissue after matrix-associated autologous chondro-
cyte transplantation (MACT) with Hyalograft C® via delayed Gadolinium
Enhanced Magnetic Resonance Imaging of Cartilage (dGEMRIC) and T2
mapping over a period of one year.
Methods: We recruited 10 patients (4 female, 6 male) after MACT in
a tertiary care unit in the years 2001–2005 who were examined at two
different times with a delay of one year. The mean age at chondrocyte
transplantation was 32.2±(standard deviation) 11.0 years, the mean BMI
was 24.5±4.1 kg/m2 and the mean defect size was 3.9±1.9 cm2. Nine of
our patients had the lesion on the medial femoral condyle, one on the
lateral femoral condyle. The mean follow-up period after MACT surgery
was 4.4±2.0 range 2 to 7 years.
MR examinations were performed on a 3 Tesla MR unit (Magnetom
TimTrio, Siemens). Every patient was assessed with dGEMRIC and T2
mapping. The regions of interest (ROI) were drawn in the posterior
cartilage surface of the femoral condyle (reference) and the site of
chondrocyte transplantation throughout 2 contiguous slices. T1 and T2
ROI values of the whole repair site and of the reference were calculated.
The T1 relaxation rates (DR1) were calculated as follows: R1pre = 1/T1pre;
R1post = 1/T1post; DR1 = R1post – R1pre
At all respective MRI follow up visits we assessed the IKDC Subjective
Knee Form, the Lysholm Score and a modiﬁed Cincinnati knee rating.
Results: The clinical scores did not change signiﬁcantly from the ﬁrst
to the second evaluation. The Lysholm score was 81.6 and 84.7, the
IKDC subjective score was 66.1 and 65.2 and the modiﬁed Cincinnati
knee rating was 6.5 and 7.4 respectively. DR1 (1/sec) was 1.06±0.58
and 0.84±0.41 in repair tissue and 0.56±0.27 and 0.51±0.23 in healthy
reference cartilage. The relative DR1 (rDR1; ratio between RT and healthy
cartilage) for repair tissue were 1.89 and 1.65 respectively. The T2
values were 43.8±8.4ms and 45.0±8.7ms for RT and 45.5±4.5ms and
44.9±5.9ms for healthy cartilage tissue.
Conclusions: This preliminary report demonstrates that it is feasible to
prospectively assess the quality of cartilage repair tissue non-invasively
with T2 mapping and dGEMRIC. We found both techniques to indicate
that the properties of the RT were more similar to native cartilage at the
second MRI visit. The rDR1 decreased, which suggests a slight increase
in the glycosaminoglycane concentration of repair cartilage compared to
healthy cartilage. However, neither technique yielded signiﬁcantly different
values at the respective follow-up examinations.
Limitations of our study predominantly concern the low number of patients
and the lack of histologic evaluation. Still, the fact that MRI parameters
of Hyalograft C® repair tissue were comparable at both follow-up visits
agreed well with the clinical ﬁndings. Hyalograft repair tissue apparently
remained stable at mid-term follow up in the subjects examined in this
study.
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Purpose: Biomechanical loading regulates expression and suppression
of a plethora of genes involved in cartilage homeostasis, pathogenesis,
and repair. Nevertheless, how these actions of mechanical signals affect
the regulation of overall gene transcription is as yet unclear. High density
focused microarray technology provides a powerful tool to interrogate
overall changes in gene transcription in response to various actions of
mechanical signals in parallel. Here we dissected the transcriptome of
chondrocytes in response to various magnitudes of mechanical forces,
followed by real-time PCR analysis of candidate genes and their products
to delineate the extent of molecular changes that are regulated by
biomechanical signals.
Methods: Articular chondrocytes from the knees of 12−14-weeks-
old Sprague-Dawley rats were cultured in TCM [Ham/F12, 10% FBS,
pen/strep and 2mM L-glutamine], and used in ﬁrst two passages. Chon-
drocytes (4×105/scaffold) were grown on PCL microﬁber scaffolds were
subjected to unconﬁned dynamic compressive forces (DCF) using a
custom-designed, computer-controlled device consisting of a vertical
translation stage and a servo controller (Aerotech, PA). Five different
treatment regimens were: (i) untreated controls; (ii) cells treated with Il-1b;
(iii) cells treated with 10% DCF at 0.5Hz; (iv) cells treated with DCF and
Il-1b; and (v) cells treated with 30% DCF at 0.5Hz. The regulation of RNA
expression was carried out by Gene chip analysis with rat genome survey
microarrays (Affymatrix), and by real time PCR using SYBR green or
Taqman primers and probes. Determination of select proteins was carried
out by Western blot analysis, using each protein speciﬁc antibodies.
Results: The approach standardized in this study enabled detection of
wide array of genes that are activated in response to biomechanical sig-
nals of magnitudes that inhibit proinﬂammatory genes, induce reparative
genes, or are traumatic. We have utilized articular chondrocytes that are
in second passage to prevent phenotypic changes. The characterization
of anabolic and catabolic genes in chondrocytes in the absence or pres-
ence of Il-1b included quantization of gene clusters that are associated
with inﬂammation. Brieﬂy, Il-1b and DTF of high/traumatic magnitudes
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induced a 10 fold or greater upregulation of several proinﬂammatory
genes, including cytokines Il-1b, Il-6, Il-8, Il-12, Il-17, and mediators,
COX-2, iNOS, MMP-1, MMP-3, MMP-4, MMP-7, MMP-9, MMP-13. How-
ever, these genes were expressed at negligible to very low density
in unstimulated control chondrocytes. Cluster analysis of chondrocytic
genes in response to low/physiological DTF showed that these signals
markedly regulate genes associated with chondrocyte growth and pro-
liferation, BMP-2, SOX-9, GDF-5, TGF-b, BMP-4, BMP-7, IGF-1, IGF-2;
genes associated with cartilage extracellular matrix, proteoglycans and
collagens, apoptosis, cell cycle associated genes, signaling cascades,
MAP kinases, NF-kB cascade, SMADs, and intracellular structural pro-
teins (actin, tubulin, vimentin, etc), adhesion molecules.
Conclusions: The results demonstrate that mechanical signals dynami-
cally cause complex magnitude-dependent gene regulation. Certain gene
clusters or representative genes are distinct, whereas others overlap in
response to low or high magnitudes of DTF. This differential magnitude-
dependent gene regulation may play a key role to ultimately allow the
remarkable and beneﬁcial/detrimental effects of mechanical signals that
are realized at cartilage level.
Acknowledgement: NIH AT00646, AR04878, NIDCR DE15399.
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Purpose: KBD) is an endemic osteoarthropathy which is mainly charac-
terised by the degeneration and necrosis of hyaline articular cartilage. At
present the etiology and pathogenesis of KBD is unclear. The aim of this
study was to investigate the expression of proteoglycan, hyaluronic acid
(HA) receptor CD44 and other factors that regulate cartilage metabolism
using the chondrocytes and tissue grafts cultured under in vitro conditions
that mimic some of the etiological factors that are thought to be involved
in the pathogenesis of KBD.
Methods: Different concentrations of mycotoxins suspected as etiological
factors causing KBD; i.e. nivalenol (NIV), deoxynivalenol (DON), T-2
toxin, butenolide (BUT) and moniliformin (MON), and Selenium (Se)
which is thought to abrogate KBD pathology, were added at physio-
logical concentrations to cultured chondrocytes and artiﬁcial cartilage
grafts in vitro to establish models of cartilage degeneration and necrosis
similar to that found with KBD. In addition, cartilage tissue and blood
samples were collected from KBD patients. RT-PCR was used to detect
the mRNA expression of CD44, HA synthase (HAS), aggrecan, aggre-
canases, matrix metalloproteinases (MMP) and tissue inhibitor of metallo-
proteinases (TIMPs). Corresponding protein expression was determined
using Western blot analyses. Immunohistochemistry was used to study
the effects of the mycotoxins on cartilage extracellular matrix metabolism;
i.e. neoepitopes for matrix proteinase degradation (BC-3/BC-13 & BC-
4/BC-14) and CD44. ELISAs were used to quantify Il-1b, TNF-a, MMPs,
soluble CD44 and HA levels in the culture media and KBD patient serum.
Results: A decrease of chondrocyte density and a gradual increase in
chondrocyte degeneration and necrosis were observed with the increase
of mycotoxin concentrations. Se addition partially alleviated this carti-
lage degradation, but did not change the overall trend of degenerative
changes. mRNA expression of aggrecan, TIMP-1 and -3 decreased whilst
that of CD44, HAS, aggrecanase-1 and -2, and MMPs increased in
chondrocytes cultured with the mycotoxins; Se addition showed some
changes. Extracellular matrix staining for cartilage aggrecan became
weak and non-uniform but after Se addition this matrix staining improved.
The expression of aggrecan speciﬁc degradation neoepitopes in cartilage
matrix increased in the presence of the mycotoxins, and this was reduced
after Se addition. The expression of CD44 on the chondrocyte cell
membranes decreased and that in matrix increased in the presence
of the toxins. The levels of glucuronic acid, soluble CD44 and HA in
cell culture media increased gradually with the increase of mycotoxin
concentration. After Se addition, the levels of glucuronic acid showed a
decrease, but that of soluble CD44 levels did not change. The levels of
Il-1b and TNF-a in the culture media of the toxin groups were higher than
Control groups.
Conclusions: These in vitro studies have exposed chondrocyte and
cartilage graft cultures to conditions of mycotoxin exposure that mimic
those believed to be involved in the etiology of KBD patient pathology.
Our results indicate that many of the pathogenic and degradation changes
observed in KBD patients are expressed in these model in vitro culture
systems including the abrogation of some of these effects by adding
Selenium.
Clinical Aspects/Outcomes
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Purpose: Topical treatment of painful muscular and joint complaints with
comfrey root ointment has often been questioned in terms of efﬁcacy.
However, several randomised controlled trials (RCT) impressively showed
the efﬁcacy and safety in blunt injuries and muscle pain of the back. Most
recent data conﬁrmed even superiority versus topical diclofenc in acute
unilateral ankle sprains. However, more clinical trials were demanded to
prove the efﬁcacy in further painful disorders, like osteoarthritis.
The aim of this study was to demonstrate the therapeutic efﬁcacy and
safety of a comfrey root extract ointment (Extr. Rad. Symphyti) in the
treatment of patients with painful osteoarthritis of the knee.
Methods: This randomised, double-blind, placebo-controlled study was
performed in accordance with the Declaration of Helsinki/Hong Kong
1989/Somerset 1996 as well as ICH-GCP Guidelines. 220 patients
(153 women, 67 men, mean age 57.9 years) daily received 6 g (3×2g)
of either an active ointment (Kytta-Salbe® f, containing comfrey root ﬂuid
extract 1:2, 35.0 g) or a corresponding placebo, for 21 days.
The active ointment is available in Germany and Switzerland as a Phar-
macy (P) OTC drug and in the UK on the General sales list (GSL). Pain,
stiffness and functional impairment are the important symptoms patients
seek to relieve. Therefore, the primary target variable was the Visual
Analog Scale (VAS) sum score of pain at rest and pain on movement.
Secondary target variable was the Western Ontario and McMaster Uni-
versities (WOMAC) score.
All patients met the criteria of the American College of Rheumatology.
Baseline characteristics were compared and a statistical analysis was
performed and veriﬁed that there was no statistical difference between
the verum and the placebo group.
Results: In the course of the study, the VAS sum score (primary target
variable) decreased by 51.6mm (54.7%) in the active therapy group and
by 10.1mm (10.7%) in the placebo group. The mean group difference of
41.5mm or 44.0% points was signiﬁcant (p< 0.001).
The WOMAC percentage sum score (secondary target variable) also
decreased strongly. At the end of the study, a reduction by 60.4mm
(58.0%) was observed in the active therapy group and by 14.7mm
(14.1%) in the placebo group. The mean group difference of 45.7mm
or 43.9% points was signiﬁcant (p< 0.001).
With regard to the exploratory target variables SF-36 (quality of life), angle
measurement (knee mobility), CGI (clinical global impression) and global
efﬁcacy assessment by investigator and patient, again a signiﬁcant supe-
riority was demonstrated (p< 0.001, respectively) for the phytotherapeutic
agent versus placebo. 7 patients of the active therapy group were rated
as, no longer requiring treatment.
Conclusions: The verum reduced the symptoms of osteoarthritis of the
knee signiﬁcantly. The therapy lead to reduction of pain, improved knee
mobility and better quality of life. Therefore, the present clinical trial has
demonstrated that the topical application of a comfrey root extract is a
sensible and safe treatment option for patients with painful osteoarthritis.
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Purpose: To assess the prognostic value of the clinical ACR classiﬁcation
criteria of knee osteoarthritis (OA) in general practice.
Methods: Patients consulting for non-traumatic knee complaints in gen-
eral practice aged >35 years were enrolled in the study. At baseline and
during one year follow-up knee complaints and function was assessed
by 3-monthly questionnaires. A physical examination was performed at
baseline and after one year follow-up. The prognostic value of fulﬁlling the
